Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

NeuRoPROBE

Financiado

Probing (Orphan) Nuclear Receptors in Neurodegeneration

Neurodegenerative diseases such as Alzheimer’s, Parkinson’s or Multiple Sclerosis are severe health burdens and major global challenges for societies and healthcare systems. Therapeutic interventions in these diseases are not sati... ver más

30/04/2027

LMU MUENCHEN

1M€

Presupuesto del proyecto: 1M€

Líder del proyecto

LUDWIGMAXIMILIANSUNIVERSITAET MUENCHEN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-04-26

ERC-2021-STG: ERC STARTING GRANTS Scope:Objectives

I+D

Cerrada hace 3 años

0% 100% 100%

1 Participantes

LMU MUENCHEN

1.50M€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

TARGET_SYNAPTIC_TAU Targeting Tau induced cognitive decline with antisense oligo... 150K€ Cerrado

BIO2013-48222-R DESARROLLO DE NUEVAS ESTRATEGIAS TERAPEUTICAS, BASADAS EN PH... 288K€ Cerrado

TREM2MICROENGINES TREM2 MICROglia ENGENEering for treating dementiaS (TREM2MIC... 150K€ Cerrado

NEUROINFLAM-MS Proteomics of neuroinflammatory signaling: Illuminating cell... 231K€ Cerrado

FENM4PTSD Development of a novel class of therapeutics for PTSD treatm... 4M€ Cerrado

PDC2022-133441-I00 LA FOSFOIMINOPROLINA LPIP, UN FARMACO MODIFICADOR DE LA ENFE... 132K€ Cerrado

Duración del proyecto: 60 meses Fecha Inicio: 2022-04-26
Fecha Fin: 2027-04-30

Líder del proyecto

LUDWIGMAXIMILIANSUNIVERSITAET MUENCHEN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 1M€

Descripción del proyecto Neurodegenerative diseases such as Alzheimer’s, Parkinson’s or Multiple Sclerosis are severe health burdens and major global challenges for societies and healthcare systems. Therapeutic interventions in these diseases are not satisfying, since there is no treatment strategy that can halt or reverse disease progression. Several failed attempts at finding a cure for neurodegeneration have significantly reduced the interest for further research - yet, more than ever, new approaches are needed. Critically missing are pharmacologically validated targets for efficient neurodegenerative disease treatment and it is exactly here that NeuRoPROBE aims to close this gap. The orphan nuclear receptors (NR) tailless homologue (TLX) and nuclear receptor related-1 protein (Nurr1) have been identified in knockout studies as prime candidates. However, ligands for their pharmacological control as tools for therapeutic validation are lacking. NeuRoPROBE will enable pharmacological modulation of these transcription factors as a new and groundbreaking strategy to counteract neurodegeneration. To meet its overall aim, NeuRoPROBE will (1) develop chemical probes (CP) and PROTACs for TLX and Nurr1, (2) employ generative artificial intelligence (AI) for molecular design to accelerate CP and PROTAC development, (3) establish phenotypic cellular models in 3D settings to mimic neurodegeneration, and (4) use CPs and PROTACs in the phenotypic models for pharmacological control of TLX and Nurr1 to validate their modulation in neurodegeneration. This challenging and highly multidisciplinary endeavor will profit from my strong interdisciplinary background in the field of NR ligand discovery and pharmacology as well as in AI-based molecular design. NeuRoPROBE will open new avenues towards regenerative treatments in neurodegeneration, close the gaps in pharmacological control of TLX and Nurr1, and substantially contribute to consolidating AI techniques for structural optimization.

Conecta tu I+D

Entra hoy

¿Olvide mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores